Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...
Pandemic prevention system wins $100 million award to expand surveillance in Nigeria and other parts of Africa.
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...
In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann ...
Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...
It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results